To determine if Globo H is a therapeutic target for pancreatic ductal adenocarcinoma

To determine if Globo H is a therapeutic target for pancreatic ductal adenocarcinoma

碩士 === 國立臺灣海洋大學 === 生物科技研究所 === 101

Bibliographic Details
Main Authors:	Chia-Yi Yang, 楊家宜
Other Authors:	Chia-Ning Shen
Format:	Others
Language:	zh-TW
Published:	2013
Online Access:	http://ndltd.ncl.edu.tw/handle/23943346173575231931

Similar Items

Targets (Metabolic Mediators) of Therapeutic Importance in Pancreatic Ductal Adenocarcinoma
by: Vikrant Rai, et al.
Published: (2020-11-01)

Emerging Kinase Therapeutic Targets in Pancreatic Ductal Adenocarcinoma and Pancreatic Cancer Desmoplasia
by: Justin F. Creeden, et al.
Published: (2020-11-01)

Targeting Pancreatic Ductal Adenocarcinoma (PDAC)
by: Sofia Parrasia, et al.
Published: (2021-01-01)

Therapeutic Potential of Piperlongumine for Pancreatic Ductal Adenocarcinoma
by: Mohammad, Jiyan Mageed
Published: (2019)

RNA Binding Proteins as Drivers and Therapeutic Target Candidates in Pancreatic Ductal Adenocarcinoma
by: Markus Glaß, et al.
Published: (2020-06-01)

Targeting mTOR in Pancreatic Ductal Adenocarcinoma
by: Sentia eIriana, et al.
Published: (2016-04-01)

Targeting dendritic cells in pancreatic ductal adenocarcinoma
by: Anton Deicher, et al.
Published: (2018-06-01)

Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma
by: Norihiro Sato, et al.
Published: (2016-03-01)

Therapeutic Status and Available Strategies in Pancreatic Ductal Adenocarcinoma
by: Gitika Thakur, et al.
Published: (2021-02-01)

Coagulation Signaling through PAR1 as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma
by: Aditi Kothari, et al.
Published: (2021-05-01)

From Malignant Progression to Therapeutic Targeting: Current Insights of Mesothelin in Pancreatic Ductal Adenocarcinoma
by: Christopher Montemagno, et al.
Published: (2020-06-01)

A rapid in vivo screen for pancreatic ductal adenocarcinoma therapeutics
by: Ozhan Ocal, et al.
Published: (2015-10-01)

Targeted nanoparticles for imaging incipient pancreatic ductal adenocarcinoma.
by: Kimberly A Kelly, et al.
Published: (2008-04-01)

Splice variants as novel targets in pancreatic ductal adenocarcinoma
by: Jun Wang, et al.
Published: (2017-06-01)

Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma
by: Yunzhen Qian, et al.
Published: (2020-10-01)

The Evolving Understanding of the Molecular and Therapeutic Landscape of Pancreatic Ductal Adenocarcinoma
by: Ashleigh Parkin, et al.
Published: (2018-11-01)

The Development of a Novel Therapeutic Strategy to Target Hyaluronan in the Extracellular Matrix of Pancreatic Ductal Adenocarcinoma
by: Daisuke Kudo, et al.
Published: (2017-03-01)

The Role of Stellate Cells in Pancreatic Ductal Adenocarcinoma: Targeting Perspectives
by: Yang Wu, et al.
Published: (2021-01-01)

Syndecans and Pancreatic Ductal Adenocarcinoma
by: Nausika Betriu, et al.
Published: (2021-02-01)

THE SUBTYPES OF PANCREATIC DUCTAL ADENOCARCINOMAS
by: Apeksha Kakkar, et al.
Published: (2016-12-01)

Novel agents for pancreatic ductal adenocarcinoma: emerging therapeutics and future directions
by: Yiyin Zhang, et al.
Published: (2018-01-01)

Metabolism remodeling in pancreatic ductal adenocarcinoma
by: Jin-Tao Li, et al.
Published: (2019-11-01)

Pharmacological targeting of the autophagy pathway in pancreatic ductal adenocarcinoma cells
by: Parzick, James Cole
Published: (2021)

The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy
by: Daniel R. Principe, et al.
Published: (2021-07-01)

Pancreatic Ductal Adenocarcinoma Associated with Autoimmune Pancreatitis
by: Raffaele Pezzilli, et al.
Published: (2011-07-01)

The role of survivin in the progression of pancreatic ductal adenocarcinoma (PDAC) and a novel survivin-targeted therapeutic for PDAC.
by: Matthew Brown, et al.
Published: (2020-01-01)

Genetic Determinants and Potential Therapeutic Targets for Pancreatic Adenocarcinoma
by: Robert eReznik, et al.
Published: (2014-03-01)

An Immunological Glance on Pancreatic Ductal Adenocarcinoma
by: Michael Karl Melzer, et al.
Published: (2020-05-01)

Apoptotic pathways in pancreatic ductal adenocarcinoma
by: Saur Dieter, et al.
Published: (2008-07-01)

Features of immunophenotype of pancreatic ductal adenocarcinoma
by: A. V. Evseyev
Published: (2014-12-01)

Photodynamic Therapy for Pancreatic Ductal Adenocarcinoma
by: Vida Karimnia, et al.
Published: (2021-08-01)

Cell of origin in pancreatic ductal adenocarcinoma
by: Lee, Alex Y. L.
Published: (2017)

Investigating the origins of pancreatic ductal adenocarcinoma
by: Machado de Morais Ferreira, R.
Published: (2015)

Surgical Treatment of Pancreatic Ductal Adenocarcinoma
by: Kongyuan Wei, et al.
Published: (2021-04-01)

Surgical Treatment of Pancreatic Ductal Adenocarcinoma
by: Sohei Satoi
Published: (2021-08-01)

Surgical Treatment of Pancreatic Ductal Adenocarcinoma
Published: (2021)

Aptamers: a novel targeted theranostic platform for pancreatic ductal adenocarcinoma
by: Q. Li, et al.
Published: (2020-08-01)

Diagnostic and therapeutic recommendations in pancreatic ductal adenocarcinoma. Recommendations of the Working Group of the Polish Pancreatic Club
by: Katarzyna Winter, et al.
Published: (2019-03-01)

KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities
by: Claudio Luchini, et al.
Published: (2020-10-01)

Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma: Therapeutic Opportunities and Clinical Challenges
by: Ashleigh R. Poh, et al.
Published: (2021-06-01)